neoechinulin

structure

Networked: 4 relevant articles (0 outcomes, 2 trials/studies)

1.	Infections 02/01/2017 - "Many marine natural products (MNPs)-for example, neoechinulin B-have been found to be promising drug candidates to alleviate the mortality and morbidity rates caused by drug-resistant infections, and several MNP-based anti-infectives have already entered phase 1, 2, and 3 clinical trials, with six approved for usage by the US Food and Drug Administration and one by the EU. " 01/01/2022 - "Whereas, another analogue, Neoechinulin B tends to interfere with the cellular mechanism thereby, inhibiting the entry of influenza A virus and it targets Liver X receptor (LXR) and decreases the infection rate of Hepatitis C. "
2.	Human Influenza (Influenza) 03/26/2015 - "In addition, neoechinulin B was still efficient in inhibiting influenza A/WSN/33 virus propagation even after a fifth passage. " 03/26/2015 - "Mechanism of action studies indicated that neoechinulin B binds to influenza envelope hemagglutinin, disrupting its interaction with the sialic acid receptor and the attachment of viruses to host cells. "
3.	Parkinson Disease (Parkinson's Disease) 12/23/2019 - "(-)-Cryptoechinuline B (1b) and neoechinulin C (5) protected the neuronal cells against paraquat-induced damage in a Parkinson's disease model. "
4.	Hepatitis C 01/01/2022 - "Whereas, another analogue, Neoechinulin B tends to interfere with the cellular mechanism thereby, inhibiting the entry of influenza A virus and it targets Liver X receptor (LXR) and decreases the infection rate of Hepatitis C. "

1.	Hemagglutinins (Hemagglutinin)
2.	sialic acid receptor
3.	Paraquat
4.	Liver X Receptors